In Focus by The Hindu

In collaboration with The Hindu’s data team, this episode comes to you on the cusp of an impending decision on extending the 21-day lockdown period in order to battle the spread of COVID-19. We discuss two data points in the context of a possible extension in the lockdown period — the effect that the lockdown has had thus far on unemployment rates and the State-wise tracker for confirmed cases, deaths and testing rates that provide a real-time view of where each State stands as the stipulated end of the lockdown period draws closer. We also discuss an interesting data point about Japan that provides some context about where India is at the moment.Guest: Srinivasan Ramani, Deputy National Editor, The Hindu.(Recorded on April 8, 2020)Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

After 76 days, the lockdown in the Chinese city of Wuhan, where the novel coronavirus originated, was lifted on April 8. As many parts of China now emerge out of various stages of shutdown, residents describe a ‘new normal’ in terms of how cities function and how they go about their day-to-day lives. Could China’s experience shed some light on how post-lockdown life might pan out in India?Interview by Ananth KrishnanGuests: Danny Geevarghese is an independent Indian journalist who has been living in Beijing since 2011; Hu Jianlong is a Chinese entrepreneur and writer who works in the start-up space in Beijing.Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

In the 18th episode of our coverage of developments on the COVID-19 front, we discuss the drug hydroxychloroquine after Indian lifted a ban on its export on Tuesday. There are questions about whether this is in response to U.S. president Donald Trump threatening retaliatory action given that the U.S. had placed an order some time before the ban on exports was put in place.India is the world's largest producer of hydroxychloroquine, a drug used in the treatment of malaria which many countries now believe can be repurposed for treating COVID-19 patients. However, despite the global race for the drug, has the efficacy of HCQ actually been borne out by testing?We also discuss the possible extension of the 21-day lockdown.Joining us as usual are National Editor Suhasini Haidar and Deputy Science Editor Jacob Koshy.(Recorded on April 7, 2020)Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

With her extensive experience in government, working in the public health space, former Union Health Secretary K. Sujatha Rao is at the very heart of the debate on the global Coronavirus pandemic. In this episode of the “In Focus” podcast she discusses with Narayan Lakshman, Associate Editor at The Hindu, the critical issue of system preparedness in India, in particular the importance of rapidly building up critical health infrastructure during the lockdown, of extensive testing to slow transmission, and of future-proofing the country’s pandemic preparedness strategy. Learn more about your ad choices. Visit megaphone.fm/adchoices

In the 17th episode discussing daily developments on the COVID-19 front, we go into topics ranging from the ban on export of the drug hydroxychloroquine, which the government may be reconsidering given that several countries have placed orders to use the drug both as treatment and as a prophylactic.Prime Minister Narendra Modi on Tuesday also sought suggestions on a calibrated exit strategy from the lockdown while the Health Ministry released some interesting statistics on the gender break-up of cases and the age break-up of fatalities from COVID-19. Finally, we discuss some new concepts for testing centres that States and private enterprises are introducing.Joining us as usual are National Editor Suhasini Haidar and Deputy Science Editor Jacob Koshy.(Recorded on April 6, 2020)Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

In this 16th episode of our coverage of COVID-19–related developments, we try and cover a flurry of updates in a somewhat rapid fire way. Once again, India reported its highest single-day spike in cases on Saturday, as the Indian Council for Medical Research released new guidelines on antibody-testing and the Health Ministry seems to largely be prescribing the use of ‘homemade face protectors’.We also discuss Air India flights being chartered to repatriate foreign citizens from India but not being able to bring back Indian citizens, and the various concerns over the power grid’s capacity to deal with Prime Minister Modi’s nine-minute challenge on Sunday.(Recorded on April 4, 2020)Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

Besides the obvious news point in the Prime Minister’s video address on Friday, there’s more to discuss about the staggered exit from the 21-day lockdown that the PM discussed with Chief Ministers on Thursday, and we’ll give you a broad overview of the factors that need to be taken into consideration in this regard. Our Tamil Nadu Chief of Bureau Ramya Kannan joins us in this discussion.We also have an update on the latest COVID-19 numbers in India and a quick explainer from our Deputy Science Editor Jacob Koshy on whether the BCG vaccine could indeed give us an immunological advantage in the battle against the novel coronavirus, as an academic study has claimed.Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

To start off the 14th episode of our daily updates on COVID-19, U.S. Correspondent Sriram Lakshman describes the alarming numbers being reported in the United States — over 120,000 cases, with New York City death toll alone passing 1,000 — the response of the Trump administration and the economic impact that is already being felt by millions.We round it with quick updates by National Editor Suhasini Haidar on Prime Minister Modi’s call with Chief Ministers on Thursday to discuss a coordinated strategy for coming out of the 21-day lockdown, and Strategic Affairs Editor Atul Aneja, who is reporting on a looming problem in the Gulf countries — 23 Indians were diagnosed with COVId-19 in Kuwait on Thursday.Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

As the COVID-19 pandemic relentlessly sweeps across the globe, many countries are in some form of lockdown with people being asked to stay at home and limit all forms of social interaction. With the national lockdown in India, we may have just started on a trend that many now say could be the ‘new normal’ for social interaction. This episode explores the question of mental health at a time like this, the toll that anxiety about the pandemic takes on people, the sense of isolation felt by many and what all of us can do to protect our general mental well being.Interview by Zubeda Hamid, Reporter, The HinduGuest: Dr Lakshmi Vijayakumar, Psychiatrist, Founder of Sneha (a helpline for the suicidally inclined), and WHO Consultant.Write to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices

Over the past few days, pictures and videos have come streaming in of migrants anxious to go back to their homes after the announcement of a national lockdown. In this episode we look ahead to the possible ramifications — the potential radius of the virus’ spread based on known patterns of migration, the disruption in the labour market that we will see now and what we can to provide more security for migrant workers to avoid such situations, both in the long term or in the short term in case of another lockdown being imposed.Guest: Chinmay Tumbe, Professor, Indian Institute of Management, Ahmedabad and Author of India Moving: A History of MigrationWrite to us with comments and feedback at socmed4@thehindu.co.in Learn more about your ad choices. Visit megaphone.fm/adchoices